| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-01-07 Tx date 2019-01-07 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-28,820
-131,000 vol $0.22 each |
719,000 | |
| Filed 2019-01-07 Tx date 2019-01-07 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$28,820
+131,000 vol $0.22 each |
||
| Filed 2019-01-07 Tx date 2019-01-07 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$28,820
+131,000 vol $0.22 each |
528,834 | |
| Filed 2019-01-07 Tx date 2019-01-07 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$28,820
+131,000 vol $0.22 each |
||
| Filed 2018-11-30 Tx date 2018-11-29 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,500
+20,000 vol $0.125 each |
387,834 | |
| Filed 2018-11-30 Tx date 2018-11-29 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,450
+34,500 vol $0.10 each |
367,834 | |
| Filed 2018-11-30 Tx date 2018-11-29 |
$VANC
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,250
+10,000 vol $0.125 each |
397,834 | |
| Filed 2018-05-16 Tx date 2017-12-06 |
$VANC
Vanc Pharmaceuticals Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$157,500
+450,000 vol $0.35 each |
450,000 | |
| Filed 2018-05-16 Tx date 2017-12-06 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$192,500
+550,000 vol $0.35 each |
||
| Filed 2018-05-16 Tx date 2017-12-06 |
$VANC
Vanc Pharmaceuticals Inc. |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$192,500
+550,000 vol $0.35 each |
850,000 | |
| Filed 2018-05-16 Tx date 2017-12-06 |
$VANC
Vanc Pharmaceuticals Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$8,750
+25,000 vol $0.35 each |
175,000 | |
| Filed 2018-05-16 Tx date 2017-12-06 |
$VANC
Vanc Pharmaceuticals Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,500
+150,000 vol $0.35 each |
600,000 | |
| Filed 2018-04-17 Tx date 2018-04-17 |
$VANC
Vanc Pharmaceuticals Inc. |
Emerald Health Therapeutics, Inc.
3 - 10% Security Holder of Issuer
Holder: 1160305 B.C. Ltd. (Control or Direction)
|
Warrants
50 - Grant of options
|
$999,999
+3,030,303 vol $0.33 each |
3,030,303 | |
| Filed 2018-04-17 Tx date 2018-04-11 |
$VANC
Vanc Pharmaceuticals Inc. |
Ratzlaff, Leanne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-17 Tx date 2018-04-11 |
$VANC
Vanc Pharmaceuticals Inc. |
Ratzlaff, Leanne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,250
+25,000 vol $0.21 each |
25,000 | |
| Filed 2018-04-17 Tx date 2017-11-28 |
$VANC
Vanc Pharmaceuticals Inc. |
Emerald Health Therapeutics, Inc.
3 - 10% Security Holder of Issuer
Holder: 1160305 B.C. Ltd. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-27 Tx date 2018-03-21 |
$VANC
Vanc Pharmaceuticals Inc. |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-27 Tx date 2018-03-27 |
$VANC
Vanc Pharmaceuticals Inc. |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$48,000
+200,000 vol $0.24 each |
200,000 | |
| Filed 2018-02-05 Tx date 2018-02-02 |
$VANC
Vanc Pharmaceuticals Inc. |
Shim, Dong Hyun
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,500
+150,000 vol $0.35 each |
150,000 | |
| Filed 2018-02-05 Tx date 2018-02-02 |
$VANC
Vanc Pharmaceuticals Inc. |
Shim, Dong Hyun
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|